GLOBALT Investments LLC GA cut its stake in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 3.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 35,918 shares of the technology company’s stock after selling 1,181 shares during the quarter. GLOBALT Investments LLC GA’s holdings in Amdocs were worth $3,142,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also bought and sold shares of the company. Boston Trust Walden Corp raised its position in Amdocs by 17.0% during the 2nd quarter. Boston Trust Walden Corp now owns 618,387 shares of the technology company’s stock valued at $48,803,000 after purchasing an additional 89,726 shares during the last quarter. SG Americas Securities LLC raised its position in Amdocs by 402.4% during the 2nd quarter. SG Americas Securities LLC now owns 154,968 shares of the technology company’s stock valued at $12,230,000 after purchasing an additional 124,122 shares during the last quarter. Sargent Investment Group LLC bought a new position in Amdocs during the 2nd quarter valued at approximately $289,000. BDF Gestion bought a new position in Amdocs during the 2nd quarter valued at approximately $833,000. Finally, Raymond James & Associates raised its position in Amdocs by 15.8% during the 2nd quarter. Raymond James & Associates now owns 457,477 shares of the technology company’s stock valued at $36,104,000 after purchasing an additional 62,460 shares during the last quarter. Institutional investors own 92.02% of the company’s stock.
Wall Street Analyst Weigh In
DOX has been the subject of several research reports. Stifel Nicolaus initiated coverage on Amdocs in a research report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 target price for the company. StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Thursday. Barclays decreased their target price on Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research report on Thursday. Finally, Oppenheimer increased their target price on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Amdocs currently has an average rating of “Moderate Buy” and a consensus price target of $101.83.
Amdocs Price Performance
NASDAQ:DOX opened at $83.98 on Monday. The company has a quick ratio of 1.24, a current ratio of 1.20 and a debt-to-equity ratio of 0.21. The business’s 50-day simple moving average is $88.16 and its two-hundred day simple moving average is $83.95. The stock has a market cap of $9.87 billion, a PE ratio of 19.81, a P/E/G ratio of 1.39 and a beta of 0.74. Amdocs Limited has a 52 week low of $74.41 and a 52 week high of $94.04.
Amdocs Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a $0.479 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $1.92 annualized dividend and a dividend yield of 2.28%. Amdocs’s dividend payout ratio (DPR) is 45.28%.
Amdocs Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
- Five stocks we like better than Amdocs
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 2 Cybersecurity Stocks to Buy and Hold for 2025
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Insider Buying Explained: What Investors Need to Know
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.